肿瘤来源外泌体通过递送miR-106a-5p和miR-146a-5p促进多发性骨髓瘤外周血单个核细胞诱导单核细胞型髓源性抑制细胞
该研究探讨多发性骨髓瘤(MM)细胞来源外泌体(TEXs)递送的miR-106a-5p和miR-146a-5p在单核细胞型髓源性抑制细胞(M-MDSCs)诱导中的作用。研究发现这两种miRNA上调外周血单个核细胞(PBMCs)中多种免疫抑制/炎症分子,并与CCL5和MIF协同促进M-MDSC诱导,提示新的治疗候选靶点可能改善免疫治疗疗效。
要点
- 骨髓瘤细胞来源外泌体递送的miR-106a-5p和miR-146a-5p在M-MDSC诱导中起重要作用
- 这两种miRNA上调PBMCs中IDO1、CD38、PD-L1、CCL5或MYD88等免疫抑制/炎症分子
- miR-106a-5p与miR-146a-5p呈补偿关系,并与CCL5和MIF协同促进M-MDSC诱导
核心结论
- 骨髓瘤细胞来源外泌体递送的miR-106a-5p和miR-146a-5p在MM的M-MDSC诱导中起重要作用。
- miR-106a-5p和miR-146a-5p具有补偿关系,并与CCL5和MIF协同促进M-MDSC诱导。
- 研究提示新的治疗候选靶点可能参与TEX介导的M-MDSC诱导相关细胞和分子事件,可能改善免疫治疗疗效。
研究设计与样本
- 研究为体外实验,使用骨髓瘤细胞来源外泌体(TEXs)与外周血单个核细胞(PBMCs)共培养体系。
- 研究基于作者此前发现的骨髓瘤细胞通过同时分泌CCL5和MIF诱导健康PBMCs产生M-MDSC,并探索未知介导因素。
主要发现
- 骨髓瘤细胞来源外泌体递送的miR-106a-5p和miR-146a-5p上调PBMCs中IDO1、CD38、程序性死亡配体1、CCL5或MYD88等多种免疫抑制/炎症分子。
- 上述分子特征涉及干扰素(IFN)-α反应、IFN-γ反应、炎症反应、肿瘤坏死因子-α信号和白细胞介素-6-JAK-STAT3信号。
- 这些分子特征与PBMCs与骨髓瘤细胞共培养时髓系细胞区室的增加相一致。
- miR-106a-5p和miR-146a-5p具有补偿关系,并与CCL5和MIF协同促进M-MDSC诱导。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The shift of the tumour immune microenvironment to a suppressive state promotes not only the development and progression of the disease in multiple myeloma (MM) but also the development of resistance to immunotherapy. We previously demonstrated that myeloma cells can induce monocytic myeloid-derived suppressor cells (M-MDSCs) from healthy peripheral blood mononuclear cells (PBMCs) via the concomitant secretion of CC motif chemokine ligand 5 (CCL5) and macrophage migration inhibitory factor (MIF), but an unknown mediator also promotes M-MDSC induction. This study demonstrates that miR-106a-5p and miR-146a-5p delivered by tumour-derived exosomes (TEXs) from myeloma cells play essential roles in M-MDSC induction in MM. MiR-106a-5p and miR-146a-5p upregulate various immunosuppressive/inflammatory molecules in PBMCs, such as IDO1, CD38, programmed death-ligand 1, CCL5 or MYD88, which are involved in interferon (IFN)-α response, IFN-γ response, inflammatory response, tumour necrosis factor-α signalling and Interleukin-6-JAK-STAT3 signalling. These molecular features mirror the increases in myeloid cellular compartments of PBMCs when co-cultured with myeloma cells. MiR-106a-5p and miR-146a-5p have a compensatory relationship, and these two miRNAs collaborate with CCL5 and MIF to promote M-MDSC induction. Collectively, novel therapeutic candidates may be involved in TEX-mediated sequential cellular and molecular events underlying M-MDSC induction, potentially improving the efficacy of immunotherapy.
引用
- Mizuhara K, Shimura Y, Tsukamoto T, et al. Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma. Br J Haematol. 2023. PMID: 37584109. doi:10.1111/bjh.19049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。